Dillards DDS Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 40.5%+0.2pp | 40.3%+0.1pp | 40.2%+0.2pp | 40%-0.2pp | 40.3%-0.2pp | |
| Net margin | 9.9%+1.3pp | 8.7%-0.1pp | 8.8%0.0pp | 8.7%-0.1pp | 8.8%-0.2pp | |
| Returns | ||||||
| Return on equity | 33.8%+1.9pp | 31.9%+2.9pp | 29%-0.8pp | 29.8%-1.2pp | 30.9%-3.1pp | |
| Return on invested capital | 51.8%+9.7pp | 42.1%-2.9pp | 44.9%+1.0pp | 43.9%+1.7pp | 42.3%-1.7pp | |
| Efficiency | ||||||
| Asset turnover | 1.6×-0.2× | 1.9×+0.3× | 1.6×-0.2× | 1.8×+0.1× | 1.7×-0.2× | |
| Liquidity | ||||||
| Current ratio | 2.4×-0.3× | 2.6×+0.5× | 2.2×-0.5× | 2.7×+0.3× | 2.4×-0.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Net debt / EBITDA | -0.8×-0.2× | -0.6×+0.3× | -0.9×-0.2× | -0.8×-0.1× | -0.6×-0.2× | |
| Valuation | ||||||
| Market capitalization | $8.89B-6.3% | $9.49B+1.2% | $9.37B+28.5% | $7.29B+41.0% | $5.17B-30.6% | |
| Price / earnings | 13.5×-3.1× | 16.6×+0.5× | 16.1×+3.5× | 12.7×+3.7× | 9×-3.6× | |
| Price / sales | 1.3×-0.1× | 1.4×0.0× | 1.4×+0.3× | 1.1×+0.3× | 0.8×-0.3× | |
| Price / book | 4.4×-0.9× | 5.3×+0.8× | 4.6×+0.8× | 3.8×+1.0× | 2.8×-1.4× | |
| EV / EBITDA | 8.2×-2.1× | 10.3×+0.6× | 9.7×+2.1× | 7.5×+2.3× | 5.2×-2.6× | |
| Dividend yield | 5.5%+0.4pp | 5.1%+0.7pp | 4.4%-1.3pp | 5.7%-2.3pp | 8%+2.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Dillards's ratios come from?
- Every ratio is computed from Dillards's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
